NTRA Natera
- 123.440
- -0.720-0.58%
- 124.570
- +1.130+0.92%
Natera News
Bernstein Maintains Outperform on Natera, Raises Price Target to $135
CCORF Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $150
Natera Is Maintained at Outperform by Leerink Partners
Leerink Partners Maintains Natera(NTRA.US) With Buy Rating, Announces Target Price $150
Natera Analyst Ratings
Goldman Sachs Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $140
BTIG Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $150
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $132
Natera Analyst Ratings
Piper Sandler Reiterates Overweight on Natera, Maintains $150 Price Target
Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $150
TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $145
Strong Buy Rating for Natera's MRD Testing Backed by Promising Clinical Data and Potential for Improved Survival Outcomes
TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $145
TD Cowen Reaffirms Their Buy Rating on Natera (NTRA)
CCORF Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $145
Craig-Hallum Maintains Natera(NTRA.US) With Buy Rating
Natera Is Maintained at Buy by Canaccord Genuity
Natera Price Target Raised to $145.00/Share From $130.00 by Canaccord Genuity
Natera Analyst Ratings
Analysis
Price Target
No Data
No Data